Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-25 @ 4:45 PM
NCT ID: NCT03810703
Description: None
Frequency Threshold: 0
Time Frame: Through study completion, an average of 5 weeks
Study: NCT03810703
Study Brief: Differential Responses to Drugs and Sweet Tastes
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Arm Participant will receive placebo oral capsule during this four hour session. Placebo oral capsule: Placebo oral capsule 0 None 0 31 0 31 View
Amphetamine 10 mg Arm Participant will receive d-amphetamine 10 mg oral capsule during this four hour session. d-amphetamine 10 mg oral capsule: d-amphetamine 10 mg oral capsule 0 None 0 31 0 31 View
Amphetamine 20 mg Arm Participant will receive d-amphetamine 20 mg oral capsule during this four hour session. d-amphetamine 20 mg oral capsule: d-amphetamine 20 mg oral capsule 0 None 0 31 0 31 View
Serious Events(If Any):
Other Events(If Any):